AstraZeneca
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.
- Conditions
- First Posted Date
- 2003-07-18
- Last Posted Date
- 2011-01-26
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 180
- Registration Number
- NCT00065117
- Locations
- 🇺🇸
Research Site, Pittsburgh, Pennsylvania, United States
Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes
- Conditions
- Interventions
- First Posted Date
- 2003-07-11
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 47
- Registration Number
- NCT00064714
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)
- Conditions
- First Posted Date
- 2003-06-10
- Last Posted Date
- 2016-11-23
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1000
- Registration Number
- NCT00062582
- Locations
- 🇺🇸
ATLANA Pharma, Cities in Colorado, Colorado, United States
🇵🇪ALTANA Pharma, Cities in Peru, Peru
Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
- Conditions
- First Posted Date
- 2003-05-21
- Last Posted Date
- 2010-11-15
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 3200
- Registration Number
- NCT00061022
- Locations
- 🇬🇧
Research Site, Newcastle-upon-Tyne, United Kingdom
Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression
- Conditions
- First Posted Date
- 2003-05-08
- Last Posted Date
- 2011-01-26
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT00060489
A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-03-04
- Last Posted Date
- 2012-10-31
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 22
- Registration Number
- NCT00055471
- Locations
- 🇺🇸
Research Site, Madison, Wisconsin, United States
Arimidex in McCune Albright Syndrome
- First Posted Date
- 2003-02-26
- Last Posted Date
- 2015-09-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 40
- Registration Number
- NCT00055302
- Locations
- 🇬🇧
Research Site, London, United Kingdom
Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination
- First Posted Date
- 2002-09-05
- Last Posted Date
- 2015-02-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 155
- Registration Number
- NCT00044668
- Locations
- 🇭🇺
Uzsoki Street Municipal Hospital, Budapest, Hungary
🇭🇺Peterfy Teaching Hospital, Budapest, Hungary
🇭🇺Diagnostic Units Hungary Kft., Budapest, Hungary
Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide
- Conditions
- Interventions
- First Posted Date
- 2002-09-05
- Last Posted Date
- 2015-05-21
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT00044707
- Locations
- 🇺🇸
ICSL-Clinical Studies, Fort Lauderdale, Florida, United States
Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
- First Posted Date
- 2002-09-05
- Last Posted Date
- 2015-02-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 156
- Registration Number
- NCT00044694
- Locations
- 🇺🇸
Carolina Advanced Research, Cary, North Carolina, United States
🇺🇸Fallen Timbers Internal Medicine, LLC, Maumee, Ohio, United States
🇺🇸Utah Diabetes Center at the University of Utah, Salt Lake City, Utah, United States